Emily Faucette
Investor Relations Contact bij TALIS BIOMEDICAL CORPORATION
Profiel
Emily Faucette is currently the SVP-Communications & Investor Relations at Talis Biomedical Corp.
Prior to this, she was the Senior VP-Global Corporate Affairs & IR at Portola Pharmaceuticals LLC in 2020.
She also held the position of Vice President-IR & Corporate Communications at Genomic Health, Inc. Ms. Faucette completed her undergraduate degree at American University.
Actieve functies van Emily Faucette
Bedrijven | Functie | Begin |
---|---|---|
TALIS BIOMEDICAL CORPORATION | Investor Relations Contact | 01-01-2021 |
Eerdere bekende functies van Emily Faucette
Bedrijven | Functie | Einde |
---|---|---|
PORTOLA PHARMACEUTICALS, INC. | Investor Relations Contact | 01-07-2020 |
GENOMIC HEALTH, INC. | Investor Relations Contact | - |
Opleiding van Emily Faucette
American University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
TALIS BIOMEDICAL CORPORATION | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Portola Pharmaceuticals LLC
Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA. | Health Technology |
Genomic Health, Inc.
Genomic Health, Inc. Medical SpecialtiesHealth Technology Genomic Health, Inc. engages in the provision of genomic-based diagnostic tests. Its tests analyze the underlying biology of cancers, allowing physicians and patients to make individualized treatment decisions. The firm uses a platform which translates a massive amount of clinical and genomic data into clinically actionable results for treatment planning. The company was founded by Patrick F. Terry, Joffre B. Baker, Randal W. Scott, and Steven Shak in August 2000 and is headquartered in Redwood City, CA. | Health Technology |